We discovered that the expression of epithelial markers E-cadherin decreased and the expression of mesenchymal markers N-cadherin and Vimentin increased after following TGF-β1 treatment in a dose-dependent manner in LN18 and U87 GBM cells (Figure 1(b)). This evidence concerns the gene VIM and glioblastoma.